Produits et services

Tubes and pipes for medical purposes.

Produits et services

Tubes and pipes for medical purposes.

Produits et services

Tubes and pipes for medical purposes.

Produits et services

Tubes and pipes for medical purposes.

Abrégé

According to an example aspect of the present invention, there is provided an acetaldehyde-binding preparation for use in a method for improving the structure and physiological function of gastric mucosa among subjects with Helicobacter pylori-associated or autoimmune type atrophic gastritis, or with long-term use of PPIs.

Classes IPC  ?

• A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
• A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
• A61K 9/48 - Préparations en capsules, p. ex. de gélatine, de chocolat
• A61P 1/04 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des ulcères, des gastrites ou des œsophagites par reflux, p. ex. antiacides, antisécrétoires, protecteurs de la muqueuse
• G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides

Produits et services

Tubes and pipes for medical purposes.

Produits et services

Tubes and pipes for medical purposes.

Abrégé

According to an example aspect of the present invention, there is provided a novel combination of two non-invasive tests and their application in the first-line detection of subjects with dyspepsia and other non-specific abdominal symptoms.

Classes IPC  ?

• G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
• G01N 33/574 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour le cancer
• G01N 33/72 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir les pigments du sang, p. ex. l'hémoglobine, la bilirubine

Abrégé

According to an example aspect of the present invention, there is provided a novel multipurpose tube system for collection, handling and storage of biological and non-biological samples.

Classes IPC  ?

• A61B 10/00 - Instruments pour le prélèvement d'échantillons corporels à des fins de diagnostic Autres procédés ou instruments pour le diagnostic, p. ex. pour le diagnostic de vaccination ou la détermination du sexe ou de la période d'ovulationInstruments pour gratter la gorge
• B01L 3/00 - Récipients ou ustensiles pour laboratoires, p. ex. verrerie de laboratoireCompte-gouttes

Abrégé

elicobacter pylori elicobacter pylori -associated or autoimmune type atrophic gastritis, or with long-term use of PPIs.

Classes IPC  ?

• A61P 1/04 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des ulcères, des gastrites ou des œsophagites par reflux, p. ex. antiacides, antisécrétoires, protecteurs de la muqueuse
• A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
• A61K 47/50 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p. ex. les supports ou les additifs inertesAgents de ciblage ou de modification chimiquement liés à l’ingrédient actif l’ingrédient non actif étant chimiquement lié à l’ingrédient actif, p. ex. conjugués polymère-médicament
• G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides

Abrégé

According to an example aspect of the present invention, there is provided an improved method for screening or examining a symptomless subject or a subject having symptoms of an autoimmune disease, wherein the method and relating quantitative measurement of relevant bio markers is carried out in one microplate set-up.

Classes IPC  ?

• G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides

Abrégé

According to an example aspect of the present invention, gastrin-17 examination relates to the use of gastrin-17 as biomarker for screening symptomless subjects and examining subjects having dyspeptic and/or reflux symptoms in order to find out healthy subjects and subjects with atrophic gastritis. The present invention provides a simple, fast and cost effective method and test for the risk assessment of peptic ulcer disease and diagnosis of atrophic gastritis with related risks.

Classes IPC  ?

• G01N 33/569 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour micro-organismes, p. ex. protozoaires, bactéries, virus
• G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides

Produits et services

Monoclonal antibodies; Chemical reagents for analytical measuring and diagnostic tests; Calibration reagents for analytical measuring and diagnostic tests for medical purposes; Pharmaceuticals; Sanitary preparations for medical purposes. Laboratory equipment, particularly in vitro diagnostic equipment, particularly for testing, analysis and diagnosing of blood samples; In vitro diagnostic test kits for laboratory use; Microtiter plate; Liquid and reagent analysers; Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; Reagent tanks; Washing apparatus and equipment for laboratory purposes; Calibration apparatus and instruments; Computer programs and computer software relating to the medical field; Testing software; Computer programs and computer software relating to the treatment of liquids. Manual and automated analysers for detecting diseases, health disorders and infections in humans; Testing apparatus for medical purposes; Diagnostic apparatus for medical purposes; Testing apparatus for medical purposes; Testing instruments for medical diagnostic purposes. Calibration services, maintenance of computer software for liquid dispensing and application software programming services for liquid dispensing, such as reprogramming of liquid dispensing devices and custom design configuration; Development of all the aforesaid services; Medical laboratory services; Medical research services. Medical screening; Medical diagnostic services; Medical analysis services.

Produits et services

Chemical reagents for the measuring of analytes and for diagnostic tests. Laboratory equipment, in particular devices for in vitro diagnostic use, particularly for blood tests, blood analysis, and diagnostics; in vitro diagnosis kits for laboratory use; microtiter plates; liquid and reagent analysers; washing apparatuses and devices for laboratory use; calibration apparatuses and devices.

Abrégé

According to an example aspect of the present invention, there is provided an improved method for screening of asymptomatic and symptomatic subjects with Helicobacter pylori infection, atrophic gastritis with related risks and/or disturbed gastric function based on whole blood samples, sample collection timeand sample storage temperature, as well as relevant biomarker content analysis.

Classes IPC  ?

• G01N 33/74 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des hormones
• G01N 35/00 - Analyse automatique non limitée à des procédés ou à des matériaux spécifiés dans un seul des groupes Manipulation de matériaux à cet effet
• G06F 19/00 - Équipement ou méthodes de traitement de données ou de calcul numérique, spécialement adaptés à des applications spécifiques (spécialement adaptés à des fonctions spécifiques G06F 17/00;systèmes ou méthodes de traitement de données spécialement adaptés à des fins administratives, commerciales, financières, de gestion, de surveillance ou de prévision G06Q;informatique médicale G16H)

Produits et services

Medical research laboratory services; medical research services. Medical testing; medical diagnostic services; medical analysis services.

Abrégé

The present invention concerns a non-toxic solid pharmaceutical composition for oral administration for use in preventing hangover symptoms, wherein the composition contains one or more cysteine compounds from the group of L-cysteine, D-cysteine and N- acetyl-cysteine, combined with one or more additives, and optionally a combination of B- vitamins.

Classes IPC  ?

• A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
• A61K 31/714 - Cobalamines, p. ex. cyanocobalamine, vitamine B12
• A61K 31/51 - Thiamines, p. ex. vitamine B1
• A61K 31/525 - Iso-alloxazines, p. ex. riboflavines, vitamine B2
• A61K 31/455 - Acide nicotinique, c.-à-d. niacineSes dérivés, p. ex. esters, amides
• A61K 31/44 - Pyridines non condenséesLeurs dérivés hydrogénés
• A61K 31/519 - PyrimidinesPyrimidines hydrogénées, p. ex. triméthoprime condensées en ortho ou en péri avec des hétérocycles
• A61K 9/22 - Pilules, pastilles ou comprimés du type à libération prolongée ou discontinue
• A61K 9/52 - Préparations en capsules, p. ex. de gélatine, de chocolat du type à libération prolongée ou discontinue
• A61P 39/00 - Agents protecteurs généraux ou antipoisons
• A23L 33/15 - Vitamines
• A23L 33/175 - Acides aminés

Abrégé

The present invention concerns a method and a kit for determining the presence of occult human blood (of neoplastic or non-neoplastic origin) in a stool sample of a patient by using sensitive immunochemical detection of the hemoglobin/haptoglobin (Hb/Hp) complex in said sample. The present method thus provides tools for detection of proximal and distal colon neoplasia in patients subjected to population based (organised) or opportunistic screening for colorectal cancer.

Classes IPC  ?

• G01N 33/72 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir les pigments du sang, p. ex. l'hémoglobine, la bilirubine
• G01N 33/574 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour le cancer
• A61B 10/00 - Instruments pour le prélèvement d'échantillons corporels à des fins de diagnostic Autres procédés ou instruments pour le diagnostic, p. ex. pour le diagnostic de vaccination ou la détermination du sexe ou de la période d'ovulationInstruments pour gratter la gorge

Abrégé

The present invention relates to a cysteine releasing pharmaceutical preparation(s) for novel use in preventing and/or treating alcohol flushing and alcohol induced hypersensitivity reactions. Additionally, the invention relates to a method for eliminating histamine releasing effect of locally formed acetaldehyde in the digestive tract.

Classes IPC  ?

• A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
• A61K 9/48 - Préparations en capsules, p. ex. de gélatine, de chocolat
• A61K 9/22 - Pilules, pastilles ou comprimés du type à libération prolongée ou discontinue
• A61P 37/08 - Agents antiallergiques

Produits et services

Medicinal, pharmaceutical and veterinary preparations; Sanitary preparations for medical purposes; Dietetic food and substances adapted for medical or veterinary use, food for babies; Dietary supplements for humans and animals; Plasters, materials for dressings; Material for stopping teeth, dental wax; Disinfectants; Preparations for destroying vermin; Fungicides, herbicides. Surgical, medical, dental and veterinary apparatus and instruments; artificial limbs, eyes and teeth; Orthopedic articles; Suture materials. Medical services; Veterinary services; Hygienic and beauty care for human beings or animals; Agriculture, horticulture and forestry services.

Abrégé

The present invention concerns a pharmaceutically acceptable composition containing one or more cysteine compounds selected from L-cysteine, D-cysteine and N-acetylcysteine, as active agent(s), most suitably formulated for controlled release, for use in treating acute hypersensitivities, when administered in a single dose of 300 to 1500 mg of said cysteine. The invention also concerns a pharmaceutically acceptable composition containing said cysteine compound(s), most suitably formulated for controlled release, for use in preventing the onset of said acute hypersensitivities, when administered to give a daily dose of cysteine of 200 to 3000 mg. Optionally, these cysteine compound(s) can be administered in combination with one or more β2 agonists or one or more corticosteroids, or both.

Classes IPC  ?

• A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
• A61K 31/573 - Composés contenant des systèmes cycliques du cyclopenta[a]hydrophénanthrèneLeurs dérivés, p. ex. stéroïdes substitués en position 17 bêta par une chaîne à deux atomes de carbone, p. ex. prégnane ou progestérone substitués en position 21, p. ex. cortisone, dexaméthasone, prednisone ou aldostérone
• A61K 31/58 - Composés contenant des systèmes cycliques du cyclopenta[a]hydrophénanthrèneLeurs dérivés, p. ex. stéroïdes contenant des hétérocycles, p. ex. danazol, stanozolol, pancuronium ou digitogénine
• A61K 31/137 - Arylalkylamines, p. ex. amphétamine, épinéphrine, salbutamol, éphédrine
• A61K 31/167 - Amides, p. ex. acides hydroxamiques ayant des cycles aromatiques, p. ex. colchicine, aténolol, progabide ayant l'atome d'azote d'un groupe carboxamide lié directement au cycle aromatique, p. ex. lidocaïne, paracétamol
• A61P 11/06 - Antiasthmatiques

Abrégé

Gastrin-17 examination relates to the use of gastrin-17 as biomarker for screening symptomless subjects and examining a subject having symptoms in order to find out healthy subjects and subjects with atrophic gastritis due to Helicobacter pylori infection or autoimmune disease. The present invention provides a simple, fast and cost effective method and test for the risk assessment of peptic ulcer disease and diagnosis of atrophic gastritis with related risks.

Classes IPC  ?

• G01N 33/74 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des hormones
• G01N 33/569 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour micro-organismes, p. ex. protozoaires, bactéries, virus
• G01N 33/574 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour le cancer

Abrégé

The present invention relates to a non-toxic composition containing one or more cysteine compounds selected from L-or D-cysteine, N-acetyl cysteine for decreasing the risk of a subject contracting cancer of the mouth and of the stomach, by locally binding both oxygen radicals and aldehydes present in the mouth and in the stomach, the composition being formulated with the help of two or more additives into a layered mixture, added into capsules or tablets, whereby these units contain one or more inner controlled release layers.

Classes IPC  ?

• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
• A61K 35/00 - Préparations médicinales contenant des substances ou leurs produits de réaction de constitution non déterminée

Abrégé

The present invention concerns a non-toxic solid pharmaceutical composition for oral administration, containing one or more cysteine compounds from the group of L-cysteine, D-cysteine and N-acetyl cysteine, combined with one or more additional active agents, at least one of which being selected from cystine, glutathione and methionine, the composition further containing one or more pharmaceutical additives. Further, the invention concerns a method for reducing the incidence of severe headaches, particularly migraine and/or cluster headaches.

Classes IPC  ?

• A61K 31/195 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe amino
• A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
• A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
• A61K 9/68 - Préparations médicinales caractérisées par un aspect particulier du type chewing-gum
• A61K 9/20 - Pilules, pastilles ou comprimés
• A61K 38/06 - Tripeptides
• A61K 38/44 - Oxydoréductases (1)

Abrégé

The present invention concerns a pharmaceutically acceptable composition containing a cysteine selected from L-cysteine, D-cysteine and N-acetylcysteine, as an active agent, for use in treating atrophic gastritis, when administered in a dose of 300 to 1500 mg per day of said cysteine during a time period of at least 2 months, or for 3 months, or even 4 months. The invention also concerns a method for treating subjects suffering from atrophic gastritis, including administering to said subjects a composition according to the invention, including a cysteine as an active agent, using said dosage regimen.

Classes IPC  ?

• A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
• A61K 9/22 - Pilules, pastilles ou comprimés du type à libération prolongée ou discontinue
• A61P 1/04 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des ulcères, des gastrites ou des œsophagites par reflux, p. ex. antiacides, antisécrétoires, protecteurs de la muqueuse

Abrégé

The present invention relates to non-toxic composition containing, as active compounds, one or more aldehyde-binding compounds, such as L- or D-cysteine, N-acetyl cysteine, and the pharmaceutically acceptable salts thereof, and optionally one or more further active compounds selected from sulphites and xylitol, the composition being used for decreasing the risk of a subject contracting cancer of the stomach, and indirectly of the small intestine and the large intestine. The composition is formulated into a controlled- release formulation consisting of granules contained in a capsule.

Classes IPC  ?

• A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61P 1/04 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des ulcères, des gastrites ou des œsophagites par reflux, p. ex. antiacides, antisécrétoires, protecteurs de la muqueuse

Abrégé

The present invention relates to a non-toxic composition containing one or more cysteine compounds selected from L- or D-cysteine, N-acetyl cysteine, and the pharmaceutically acceptable salts thereof, for decreasing the risk of a subject contracting cancer of the stomach, the small intestine and the colon, by locally binding aldehydes present in the stomach, and optionally also separately the aldehydes carried to the small intestine or the colon, or both, whereby the composition is formulated with the help of two or more additives into controlled-release tablets containing at least one additive selected from cationic and gel- forming polymers, which tablets are formed from two or more separate layers with different release profiles, whereby the cysteine compounds are added both into the inner layer(s) and into the tablet material surrounding these.

Classes IPC  ?

• A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61P 1/04 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des ulcères, des gastrites ou des œsophagites par reflux, p. ex. antiacides, antisécrétoires, protecteurs de la muqueuse

Abrégé

The present invention concerns a non-toxic composition in the form of buccal tablets, sublingual tablets or lozenges, which comprises a combination of active agents including one or more aldehyde-binding cysteine compound(s) selected from the group of L-and D-cysteine, N-acetyl cysteine, and the pharmaceutically acceptable salts thereof,and xylitol, which composition further comprises one or more non-toxic additives that include one or more aromatic agents as well as one or more fillers or binders or both,and optional further additives.

Classes IPC  ?

• A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
• A61K 31/047 - Composés hydroxylés, p. ex. alcoolsLeurs sels, p. ex. alcoolates ayant plusieurs groupes hydroxyle, p. ex. sorbitol
• A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
• A61K 9/28 - DragéesPilules ou comprimés avec revêtements
• A61P 1/00 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif
• A61P 35/00 - Agents anticancéreux

Abrégé

The present invention concerns a non-toxic solid pharmaceutical composition for oral administration, containing one or more cysteine compounds from the group of L-cysteine, D-cysteine and N-acetyl cysteine, combined with one or more additional active agents, at least one of which being selected from cystine, glutathione and methionine, the composition further containing one or more pharmaceutical additives. Further, the invention concerns a method for reducing the incidence of severe headaches, particularly migraine and/or cluster headaches.

Classes IPC  ?

• A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
• A61K 38/06 - Tripeptides
• A61K 9/20 - Pilules, pastilles ou comprimés
• A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
• A61K 9/68 - Préparations médicinales caractérisées par un aspect particulier du type chewing-gum
• A61P 25/06 - Agents antimigraineux

Produits et services

Computer programs for use in diagnosing H.pylori-infection and atrophic gastritis, and for determining risk factors for gastric cancer and peptic ulcer and for providing recommendations for treatment as well as for the need and urgency of further examination in the nature of gastroscopy Providing temporary use of on-line non-downloadable software for use in diagnosing H.pylori-infection and atrophic gastritis, and for determining risk factors for gastric cancer and peptic ulcer and for providing recommendations for treatment as well as for the need and urgency of further examination in the nature of gastroscopy

Abrégé

The present invention concerns a product in the form of a non-toxic liquid composition, such as a mouthwash, or in the form of an effervescent tablet,for decreasing the risk of cancer caused by oral microbes,which composition comprises cysteine or a derivative thereof. Alternatively, the product may be in the form of a non-toxic combination product including an effervescent tablet, a powder or granules comprising cysteine or a derivative thereof and a mouthwash, the combination product being intended for decreasing the risk of cancer caused by oral microbes. The components of the combination product may be administered either at the same time or separately.

Classes IPC  ?

• A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
• A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
• A61K 9/20 - Pilules, pastilles ou comprimés
• A61K 47/00 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p. ex. les supports ou les additifs inertesAgents de ciblage ou de modification chimiquement liés à l’ingrédient actif
• A61P 35/00 - Agents anticancéreux
• A61P 31/00 - Agents anti-infectieux, c.-à-d. antibiotiques, antiseptiques, chimiothérapeutiques

Abrégé

The present invention concerns products, such as compositions or medical devices, comprising one or more compounds of the Formula I, containing one or more free sulphhydryl groups, where R1 is hydrogen or an acetyl group, and R2 is asulphhydryl groupor a C1-C5 straight chained or branched hydrocarbon chain, optionally containing one or more heteroatoms selected from O, N and S, further containing one or more free sulphhydryl groups, for use in connection with Helicobacter pylori infections or other related infections, either as such or as combinations with antibiotics, whereby the compound(s) and optionally, when present, the antibiotic(s),are mixed with one or more pharmaceutically acceptable carriers providing sustained local release in the stomachor elsewhere in the upper aerodigestive tract.

Classes IPC  ?

• A61K 31/197 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe amino les groupes amino et carboxyle étant liés à la même chaîne carbone acyclique, p. ex. acide gamma-aminobutyrique [GABA], bêta-alanine, acide epsilon-aminocaproïque ou acide pantothénique
• A61K 9/22 - Pilules, pastilles ou comprimés du type à libération prolongée ou discontinue
• A61P 1/04 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des ulcères, des gastrites ou des œsophagites par reflux, p. ex. antiacides, antisécrétoires, protecteurs de la muqueuse
• A61P 31/04 - Agents antibactériens
• A61K 47/36 - PolysaccharidesLeurs dérivés, p. ex. gommes, amidon, alginate, dextrine, acide hyaluronique, chitosane, inuline, agar-agar ou pectine

Produits et services

Dispensers for liquids and reagents, for laboratory use; dispensing robots for laboratory use.

Abrégé

This invention relates to a non-toxic composition which bind acetaldehyde present in the stomach, intestine and/or colon. The composition comprises one or more acetaldehyde-binding compound(s) comprising one or more free sulphhydryl and/or amino groups. The compound(s) are mixed with a non-toxic carrier that effects sustained release of said compound(s) in the gastrointestinal tract. This invention relates also to food additives and food compositions and packages comprising the composition.

Classes IPC  ?

• A61K 9/22 - Pilules, pastilles ou comprimés du type à libération prolongée ou discontinue

Produits et services

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.

Abrégé

The present invention relates to evaluating the performance of an automated matrix-format liquid handling system by using receptacles and caps. The invention provides a method comprising the steps of determining a receptacle weight for each receptacle, determining a mean cap weight for the caps, dispensing a volume of liquid in each receptacle by using the liquid handling system, capping each receptacle approximately simultaneously with respect to each other, determining a gross weight for each capped receptacle, and calculating the volume of liquid dispensed in each receptacle from the respective gross weight, the respective receptacle weight, and the mean cap weight. The invention further provides a kit for carrying out the method, the kit comprising a plurality of receptacles, a plurality of caps, a holder device for arranging the receptacles in accordance with liquid dispensing positions in the liquid handling system, and a capping device for capping the receptacles.

Classes IPC  ?

• B01L 3/00 - Récipients ou ustensiles pour laboratoires, p. ex. verrerie de laboratoireCompte-gouttes
• G01N 35/00 - Analyse automatique non limitée à des procédés ou à des matériaux spécifiés dans un seul des groupes Manipulation de matériaux à cet effet
• G01F 25/00 - Test ou étalonnage des appareils pour la mesure du volume, du débit volumétrique ou du niveau des liquides, ou des appareils pour compter par volume
• B67D 7/08 - Aménagements des dispositifs pour commander, indiquer, mesurer ou enregistrer la quantité ou le prix du liquide transféré
• G01F 15/02 - Compensation ou correction des variations de pression, de poids spécifique ou de température
• G01G 15/00 - Dispositions pour contrôler le poids de produits déversés dans des récipients amovibles
• G01G 17/06 - Appareils ou méthodes pour peser un produit ayant une forme ou des propriétés particulières pour peser des fluides, p. ex. des gaz, des produits pâteux et ayant les moyens de commander le remplissage ou la vidange

Abrégé

The present invention relates to a method for examining a person having the symptoms and/or biomarker indicating an autoimmune disease for the presence of atrophic gastritis. The biomarker combination, which diagnoses atrophic gastritis, acts also as a part of a biomarker panel that helps diagnosis and assessment of autoimmune disease as well. The invention relates also to products used in these methods.

Classes IPC  ?

• G01N 33/573 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour enzymes ou isoenzymes
• G01N 33/569 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour micro-organismes, p. ex. protozoaires, bactéries, virus
• G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
• G01N 33/74 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des hormones

Abrégé

The present invention relates to the use of a preparation comprising a substance that is capable of binding acetaldehyde, and to the use of a filter that is attached to a tobacco product to reduce tobacco and/or alcohol dependence.

Classes IPC  ?

• A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
• A24B 15/30 - Traitement du tabac ou des succédanés du tabac par des substances chimiques par des substances organiques
• A24D 3/14 - Emploi de matériaux particuliers pour les filtres à fumée de tabac de matériaux organiques comme matériaux additionnels
• A61P 25/32 - Médicaments pour le traitement des troubles du système nerveux des états d'abus ou de dépendance à l'alcool
• A61P 25/34 - Médicaments pour le traitement des troubles du système nerveux des états d'abus ou de dépendance au tabac

Abrégé

The present invention relates to the use of a preparation comprising a substance that is capable of binding acetaldehyde, and to the use of a filter that is attached to a tobacco product to reduce tobacco and/or alcohol dependence.

Classes IPC  ?

• A24B 15/30 - Traitement du tabac ou des succédanés du tabac par des substances chimiques par des substances organiques
• A24D 3/14 - Emploi de matériaux particuliers pour les filtres à fumée de tabac de matériaux organiques comme matériaux additionnels
• A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
• A61P 25/32 - Médicaments pour le traitement des troubles du système nerveux des états d'abus ou de dépendance à l'alcool
• A61P 25/34 - Médicaments pour le traitement des troubles du système nerveux des états d'abus ou de dépendance au tabac

Abrégé

The invention relates to a cigarette holder-type component, which is intended to be attached to a tobacco product and can be adapted to the suction head of the tobacco product so that the smoke travels through the component during smoking. The component contains porous material, into which an aqueous solution containing at least one aldehyde-binding compound has been absorbed to form an aldehyde-binding filter. In the component that is to be attached to the tobacco product, the water content of the material is kept at a level where the aldehyde-binding compounds are capable of reacting with the aldehydes in the smoke, changing them into a harmless form.

Classes IPC  ?

• A24D 3/14 - Emploi de matériaux particuliers pour les filtres à fumée de tabac de matériaux organiques comme matériaux additionnels
• A24D 3/04 - Filtres à fumée de tabac caractérisés par leur forme ou leur structure

Abrégé

The invention concerns a method for assessing the condition of the gastric mucosa in an individual, which method comprises a) determining the concentration of the biomarkers pepsinogen I (PGI) and pepsinogen II (PGII) in a sample from the said individual, and forming the biomarker ratio PGI/PGII from the concentration values obtained for PGI and PGII, b) comparing the values obtained for PGI and PGI/PGII to the respective cut-off values or reference ranges for said biomarkers, whereby a value for at least one of the markers PGI an d PGI/PGII close to or below the lower limit of its reference range or its cut-off value is indicative of corpus atrophy in said individual. If necessary, the method can be combined with as further step of determining the Helicobacter pylori antibody and gastrin-17 (G-17) concentration in a sample from the said individual.

Classes IPC  ?

• G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
• G01N 33/573 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour enzymes ou isoenzymes
• G01N 33/574 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour le cancer
• G01N 33/74 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des hormones
• G01N 33/569 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour micro-organismes, p. ex. protozoaires, bactéries, virus

Abrégé

The invention is directed to a method for testing batches of tips for pipettes, the method comprising the steps of calibrating a pipette to be tested with a recommended reference tip, fitting the pipette with a tip to be tested and performing a second calibration and recalibrating the pipette with the reference tip.

Classes IPC  ?

• G01F 25/00 - Test ou étalonnage des appareils pour la mesure du volume, du débit volumétrique ou du niveau des liquides, ou des appareils pour compter par volume
• B01L 3/02 - BurettesPipettes

Abrégé

This invention relates to a non-toxic composition which bind acetaldehyde present in the stomach, intestine and/or colon. The composition comprises one or more acetaldehyde-binding compound(s) comprising one or more free sulphhydryl and/or amino groups. The compound(s) are mixed with a non-toxic carrier that effects sustained release of said compound(s) in the gastrointestinal tract. This invention relates also to food additives and food compositions and packages comprising the composition.

Classes IPC  ?

• A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
• A61K 31/131 - Amines, p. ex. amantadine acycliques
• A23L 1/305 - Aminoacides, peptides ou protéines 
• A23L 1/00 - Aliments ou produits alimentaires; Leur préparation ou traitement (leur conservation en général A23L 3/00)
• A23L 1/30 - contenant des additifs (A23L 1/308 a priorité);;
• A23L 1/29 - Modification de la qualité nutritive des aliments; Produits diététiques ( A23L 1/09 a priorité;substituts diététiques du sel A23L 1/22)
• A61P 39/02 - Antidotes
• A61P 25/32 - Médicaments pour le traitement des troubles du système nerveux des états d'abus ou de dépendance à l'alcool
• A61P 25/34 - Médicaments pour le traitement des troubles du système nerveux des états d'abus ou de dépendance au tabac

Abrégé

This invention relates to a non-toxic composition which bind acetaldehyde present in the stomach, intestine and/or colon. The composition comprises one or more acetaldehyde-binding compound(s) comprising one or more free sulphhydryl and/or amino groups. The compound(s) are mixed with a non-toxic carrier that effects sustained release of said compound(s) in the gastrointestinal tract. These compositions are of benefit in particular to patients having atrophic gastritis or achlorhydric or low acid stomach.

Classes IPC  ?

• A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
• A61K 31/131 - Amines, p. ex. amantadine acycliques
• A23L 1/305 - Aminoacides, peptides ou protéines 
• A23L 1/00 - Aliments ou produits alimentaires; Leur préparation ou traitement (leur conservation en général A23L 3/00)
• A23L 1/30 - contenant des additifs (A23L 1/308 a priorité);;
• A23L 1/29 - Modification de la qualité nutritive des aliments; Produits diététiques ( A23L 1/09 a priorité;substituts diététiques du sel A23L 1/22)
• A61P 39/02 - Antidotes
• A61P 25/32 - Médicaments pour le traitement des troubles du système nerveux des états d'abus ou de dépendance à l'alcool
• A61P 25/34 - Médicaments pour le traitement des troubles du système nerveux des états d'abus ou de dépendance au tabac

Abrégé

This invention relates to a method for selecting a plunger-cylinder tip of a pipette and a device for carrying out the method. In the method, the dose size is entered into the control electronics of the pipetting device; the dose size is stored in the control electronics; the amount of doses is entered; and on the basis of the dose size and the amount of doses, the control electronics indicates suitable available interchangeable components on the display.

Classes IPC  ?

• B01L 3/02 - BurettesPipettes

Produits et services

Monoclonal antibodies; calibration reagents for measuring analytes and for diagnostic testing. Pipettes; pipettors; pipette tips; filters used in pipettes or pipette tips; pipette stands; pipette charging stands; liquid and reagent analyzers; containers and dispensers for liquids and reagents; automatic dispensing devices; washers and washing equipment (laboratory devices and equipment); incubators; shakers; PCR (polymerase chain reaction) equipment (laboratory equipment); pipetting accessories; bottle top dispensers; syringes for use on pipettes; microtiter plate readers; microtiter plates; processors and software for automating and calibrating liquid and reagent handling and dilution; calibration tools and equipment; calibration equipment for measuring analytes and for diagnostic testing; in vitro test kits; software for interpretation of results of diagnostic test panels. Manual and automated analyzers for use in detecting human diseases, disorders and infections. Calibration services, maintenance services relating to dispensing of liquid, pipetting application services, such as re-programming and client-related configuration of pipetting devices, development of all the above-mentioned services.

Produits et services

Chemical reagents for the measuring of analytes and for diagnostic tests. Laboratory equipment, in particular devices for in vitro diagnostic use, particularly for blood tests, blood analysis, and diagnostics; in vitro diagnosis kits for laboratory use; microtiter plates; liquid and reagent analysers; washing apparatuses and devices for laboratory use; calibration apparatuses and devices.

Produits et services

Computer software.

Produits et services

Monoclonal antibodies; calibration reagents for measuring analytes and for diagnostic testing. Pipettes; pipettors; pipette tips; filters used in pipettes or pipette tips; pipette stands; pipette charging stands; liquid and reagent analyzers; containers and dispensers for liquids and reagents; automatic dispensing devices; washers and washing equipment (laboratory devices and equipment); incubators; shakers; PCR (polymerase chain reaction) equipment (laboratory equipment); pipetting accessories; bottle top dispensers; syringes for use on pipettes; microtiter plate readers; microtiter plates; processors and software for automating and calibrating liquid and reagent handling and dilution; calibration tools and equipment; calibration equipment for measuring analytes and for diagnostic testing; in vitro test kits; software for interpretation of results of diagnostic test panels. Manual and automated analyzers for use in detecting human diseases, disorders and infections. Calibration services, maintenance services relating to dispensing of liquid, pipetting application services, such as re-programming and client-related configuration of pipetting devices, development of all the abovementioned services.

Produits et services

Checking, repair, maintenance and refurbishment of liquid metering apparatus, particularly pipettes. Calibration of liquid metering apparatus, particularly pipettes.